Company Details

  • Zhiyuan Biotchnology

  •  [Shandong,China]
  • Business Type:Manufacturer
  • Main Mark: Africa , Americas , Asia , Caribbean , Europe , North Europe , Oceania , West Europe , Worldwide , East Europe , Middle East
  • Exporter:51% - 60%
  • Certs:ISO9001, ISO14001, FDA
Inquiry Basket ( 0 )

Zhiyuan Biotchnology

Home > News > Borneol - hydroxypropyl betacyclodextrin inclusion compound
News

Borneol - hydroxypropyl betacyclodextrin inclusion compound

Borneol is also known as borneol, often as "primer and adjuvant", can promote local drug absorption, through the blood-brain barrier, Chinese patent medicine has more borneol compatibility application, cardio-cerebrovascular therapy is widely used, but it is easy to sublimate, resulting in the preparation process and storage period is very unstable.The stability and water solubility of borneol can be greatly improved by the inclusion of cyclodextrin in borneol, especially the inclusion effect of hydroxypropyl betacyclodextrin (hp-betacyclodextrin) is much better than that of betacyclodextrin.The inclusion of hp-betao-cd-borneol provides a more reliable and effective preparation route for the treatment of cardiovascular and cerebrovascular diseases with traditional Chinese medicine.In particular, it provides a method for making borneol into water-soluble injection.After hundreds of experiments, the r&d team of shandong binzhou zhiyuan biotechnology co., ltd. successfully tested borneol - hydroxypropyl betacyclic Cyclodextrin inclusion compound, which was recognized by customers.
Share to:  
Communicate with Supplier?Supplier
Klaus chen Mr. Klaus chen
What can I do for you?
Chat Now Contact Supplier